Betamethasone Dipropionate NDC 0168-0056

NDC codes

FDA NDC Directory

Product NDC (as listed)0168-0056Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00168-0056Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0168-0056-15	00168005615	1 TUBE in 1 CARTON (0168-0056-15) / 15 g in 1 TUBEMarketed from Sep 4, 1984
0168-0056-46	00168005646	1 TUBE in 1 CARTON (0168-0056-46) / 45 g in 1 TUBEMarketed from Sep 4, 1984

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Betamethasone Dipropionate
Generic name (nonproprietary): betamethasone dipropionate
Active ingredients: Betamethasone dipropionate — .5 mg/g
Dosage form: Ointment
Route: Topical
Labeler: E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 019141
Marketing start: Sep 4, 1984
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 0168-0056_0173ed23-9f7c-466e-9eba-f6859d05f987SPL ID 0173ed23-9f7c-466e-9eba-f6859d05f987SPL set ID 0173ed23-9f7c-466e-9eba-f6859d05f987RxCUI 197405UNII 826Y60901U
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400168005615 followed by a unit qualifier and the quantity

Package 00168-0056-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 29, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 019141

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 019141
Product	Strength	Form · route	Labeler	Product NDC
Betamethasone Dipropionate	Betamethasone dipropionate .5 mg/g	OintmentTopical	A-S Medication Solutions	50090-0236